← Open Payments lookup

NORA BOLANOS: Open Payments

NPI 1578964177 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,447 in 53 payments from 25 companies in 2025. Trend: 2023 $255 · 2024 $0 · 2025 $1,447

Food & beverage: $1,173Education: $274
CompanyPaymentsAmount
Janssen Biotech, Inc.9$233
Merck Sharp & Dohme LLC8$189
Stemline Therapeutics Inc.2$142
GlaxoSmithKline, LLC.1$109
Gilead Sciences, Inc.1$100
SEAGEN INC.1$75
AstraZeneca Pharmaceuticals LP3$61
GENZYME CORPORATION3$58
TerSera Therapeutics LLC3$57
Regeneron Healthcare Solutions, Inc.2$56

Products named: KEYTRUDA, Orserdu, RYBREVANT, OJJAARA, Trodelvy, TALVEY, SARCLISA, Zoladex.

Industry payments across TX — which companies pay providers there.